Vamsi Velcheti, MD MBA FASCO (@vamsivelcheti) 's Twitter Profile
Vamsi Velcheti, MD MBA FASCO

@vamsivelcheti

Professor of Medicine @ New York University, Director- Thoracic Oncology Program w/ focus on immunotherapy, epigenetics, phase 1 clinical trials

ID: 2244694079

linkhttps://www.doximity.com/pub/vamsidhar-velcheti-md calendar_today26-12-2013 12:17:20

2,2K Tweet

4,4K Followers

605 Following

ASCO (@asco) 's Twitter Profile Photo

🎙️ Vamsi Velcheti, MD MBA FASCO of @NYULangone and Charu Aggarwal, MD, MPH, FASCO of Penn Medicine discuss the current and future role of ctDNA in lung cancer management on the latest episode of the #ASCODailyNews Podcast: brnw.ch/21wRLJv

🎙️ <a href="/VamsiVelcheti/">Vamsi Velcheti, MD MBA FASCO</a> of @NYULangone and <a href="/CharuAggarwalMD/">Charu Aggarwal, MD, MPH, FASCO</a> of <a href="/PennMedicine/">Penn Medicine</a> discuss the current and future role of ctDNA in lung cancer management on the latest episode of the #ASCODailyNews Podcast: brnw.ch/21wRLJv
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

📣Join us at the 34th ANNUAL Mayo Clinic Comprehensive Cancer Center Florida #Hematology/#Oncology Reviews at Amelia Island #RitzCarlton (July 2025). Comprehensive #CME #Practical (in-person & virtual) Conference, with AMAZING speakers from Mayo Clinic & other GREAT centers. 👇🏼 tinyurl.com/56tmx6j7

📣Join us at the 34th ANNUAL 
<a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a> Florida #Hematology/#Oncology Reviews at Amelia Island #RitzCarlton (July 2025).

Comprehensive #CME #Practical (in-person &amp; virtual) Conference, with AMAZING speakers from <a href="/MayoClinic/">Mayo Clinic</a> &amp; other GREAT centers.
👇🏼
tinyurl.com/56tmx6j7
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Dr. Christine Lovly, MD, PhD, FASCO and I discuss #AACR25 highlights on the latest episode of the IASLC podcast, Lung Cancer Considered. Several important clinical updates for lung cancer management from AACR including zongertinib and aumolertinib updates. iaslc.org/iaslc-news/lun…

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Flatiron analysis of 34,510 pts with NSCLC on biomarker testing JCO Oncology Practice by Sandip Patel MD FASCO. Steady rise in biomarker testing: in 2023, 89% tested for #EGFR and 88% for #ALK. Not all receive targeted therapy though: only 84% of ALK+ receive an ALK TKI. ascopubs.org/doi/10.1200/PO…

Flatiron analysis of 34,510 pts with NSCLC on biomarker testing <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> by <a href="/PatelOncology/">Sandip Patel MD FASCO</a>. Steady rise in biomarker testing: in 2023, 89% tested for #EGFR and 88% for #ALK. Not all receive targeted therapy though: only 84% of ALK+ receive an ALK TKI.

ascopubs.org/doi/10.1200/PO…
Vamsi Velcheti, MD MBA FASCO (@vamsivelcheti) 's Twitter Profile Photo

Maintenance trials are inherently confounded by post-progression access to Rx. OS benefit may reflect sequencing bias especially with emerging agents (e.g., Dato-DXd, tarlatamab). Without clear QoL data, added toxicity may offset the modest gains—limiting practice changing

Aakash Desai, MD, MPH, FASCO (@adesaimd) 's Twitter Profile Photo

It’s only Saturday of #ASCO25 and my ❤️ is full!! Thank you ASCO for this honor, congrats to all awardees! And I am just so happy to be with my people! So honored to have received #FASCO today, and be able to share it with so many dear colleagues and friends. It’s an honor to

It’s only Saturday of #ASCO25 and my ❤️ is full!! Thank you <a href="/ASCO/">ASCO</a> for this honor, congrats to all awardees! And I am just so happy to be with my people! So honored to have received #FASCO today, and be able to share it with so many dear colleagues and friends. It’s an honor to
Vamsi Velcheti, MD MBA FASCO (@vamsivelcheti) 's Twitter Profile Photo

At #ASCO25 Rami Manochakian MD, FASCO Cancer Education Mayo ClinicFL @MayoClinic Mayo Clinic Comprehensive Cancer Center emphasized the importance of aligning educational content with the full chain of education – Who, Why, Where, What & How – while integrating core learning science principles (CLEVR): ✔️ Contrasting Cases ✔️

At #ASCO25 <a href="/RManochakian/">Rami Manochakian MD, FASCO Cancer Education</a>  <a href="/MayoClinic/">Mayo Clinic</a>FL @MayoClinic <a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a> emphasized the importance of aligning educational content with the full chain of education – Who, Why, Where, What &amp; How – while integrating core learning science principles (CLEVR):
✔️ Contrasting Cases
✔️
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

🔥🚨Hot off the press JUST published ASCO #Connection An article on: “Building an #AcademicCareer in #OncologyEducation” #Dialogue between 2 OUTSTANDING #Fellows in our program Mayo Clinic, Drs #Pai & Dina Elantably, MD, MS & me (a PROUD #ProgramDirector) 👇🏻 connection.asco.org/do/building-ac…

🔥🚨Hot off the press
JUST published <a href="/ASCO/">ASCO</a> #Connection 

An article on:
“Building an #AcademicCareer in #OncologyEducation” 

#Dialogue between 2 OUTSTANDING #Fellows in our program <a href="/MayoClinic/">Mayo Clinic</a>, Drs #Pai &amp; <a href="/DinaElantably/">Dina Elantably, MD, MS</a> &amp; me (a PROUD #ProgramDirector)

👇🏻
connection.asco.org/do/building-ac…
Vamsi Velcheti, MD MBA FASCO (@vamsivelcheti) 's Twitter Profile Photo

Air pollution harms our patients. U.S. EPA plans to roll back climate and clean air protections—time to speak up. Signing this letter Oncology Advocates United for Climate and Health Dr. Joan Schiller Lung Health Foundation takes seconds but shows we stand by our value_ docs.google.com/forms/d/e/1FAI…

Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

1/2🔥🚨Hot off the press Just published on #ASCODailyNews ASCO 📝Editorial Article by our team Mayo Clinic Comprehensive Cancer Center on: ✅#MARIPOSA trial & latest developments in #Treatment of #EGFR+ non-small cell #LungCancer (#NSCLC). Reema Tawfiq, MD Vamsi Velcheti, MD MBA FASCO 👇🏻 dailynews.ascopubs.org/do/butterfly-e…

1/2🔥🚨Hot off the press

Just published on #ASCODailyNews <a href="/ASCO/">ASCO</a>

📝Editorial Article by our team <a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a> on:

✅#MARIPOSA trial &amp; latest developments in #Treatment of #EGFR+ non-small cell #LungCancer (#NSCLC).

<a href="/ReemaTawfiqMD/">Reema Tawfiq, MD</a> <a href="/VamsiVelcheti/">Vamsi Velcheti, MD MBA FASCO</a>

👇🏻
dailynews.ascopubs.org/do/butterfly-e…
Gianrico Farrugia (@gfarrugiamd) 's Twitter Profile Photo

Dr. Roxana Dronca, a medical oncologist, colleague, and longtime friend, has created a lasting legacy for her daughter Maya through her visionary cancer care work at Mayo and through the Maya Dronca Foundation. Read more: mayocl.in/3IebhM6

Jasmine Kamboj, MD, FASCO (@jasminekambojmd) 's Twitter Profile Photo

Just listened to wonderful podcast on GU Updates by Neeraj Agarwal, MD, FASCO and Dr Jeanny Aragon-Ching. Great consolidation of updates for a community oncologist. Thanks so much!! ASCO #ASCO25 #Podcasts #ASCODailyNews #OncTwitter #MedTwitter Yüksel Ürün IMG Oncologists Hem-Onc Fellows Network

Vamsi Velcheti, MD MBA FASCO (@vamsivelcheti) 's Twitter Profile Photo

More elegant work from Swanton Lab revealing that immune control within lung tumors is subclonally heterogeneous — not all clones are equal in evading immune attack. A crucial step forward in understanding why responses to immunotherapy are often incomplete.